March 10, 2021 Hematological Cancers HEMATOLOGICAL CANCERS Investigational Treatment for Relapsed or Refractory Acute Myeloid Leukemia (AML) Acute myeloid leukemia, bone marrow, small molecule inhibitor, AXL signaling, FLT3 Signaling Next